# New Vital Pulpotomy Medications in Primary Molars

> **NCT05937100** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Mansoura University** · enrollment: 48 (estimated)

## Conditions studied

- Carious Exposure of Pulp

## Interventions

- **DRUG:** Formocresol
- **DRUG:** Biodentine
- **DRUG:** Hyaluronic acid gel

## Key facts

- **NCT ID:** NCT05937100
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-05-01
- **Primary completion:** 2025-07-01
- **Final completion:** 2025-08-01
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05937100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05937100, "New Vital Pulpotomy Medications in Primary Molars". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05937100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*